These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
660 related items for PubMed ID: 17607149
1. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin. Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N. Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149 [Abstract] [Full Text] [Related]
2. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
4. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin. Enrique-Gonzaleza A, Sánchez-Ferrándiz N, Pérez-Fernández N. Rev Laryngol Otol Rhinol (Bord); 2008 May; 129(4-5):249-54. PubMed ID: 19408504 [Abstract] [Full Text] [Related]
5. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes. Smith WK, Sandooram D, Prinsley PR. J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921 [Abstract] [Full Text] [Related]
6. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Hillman TA, Chen DA, Arriaga MA. Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193 [Abstract] [Full Text] [Related]
7. Hearing results following intratympanic gentamicin perfusion for Ménière's disease. Kyrodimos E, Aidonis I, Sismanis A. J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493 [Abstract] [Full Text] [Related]
8. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
16. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin. Perez N, Martin E, Zubieta JL, Romero MD, Garcia-Tapia R. Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282 [Abstract] [Full Text] [Related]
17. Intratympanic gentamicin therapy for Ménière's disease. Hirsch BE, Kamerer DB. Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951 [Abstract] [Full Text] [Related]
18. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections. Manrique-Huarte R, Guillén-Grima F, Perez-Fernandez N. Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673 [Abstract] [Full Text] [Related]
19. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results. Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH. Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092 [Abstract] [Full Text] [Related]
20. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy. Crane BT, Minor LB, Della Santina CC, Carey JP. Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]